Comparison between Accretion Pharmaceuticals IPO and Divine Hira Jewellers IPO.
Accretion Pharmaceuticals IPO is a SME Fixed Price IPO proposed to list at NSE SME while Divine Hira Jewellers IPO is a SME Fixed Price proposed to list at NSE SME.
| Accretion Pharmaceuticals IPO | Divine Hira Jewellers IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Fixed Price |
| Listing At | NSE SME | NSE SME |
| Lead Managers | Jawa Capital Services Pvt.Ltd. | Horizon Management Pvt.Ltd. |
| Registrar | Kfin Technologies Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | Gretex Share Broking Pvt.Ltd. | Giriraj Stock Broking Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Anchor Investor | Anchor Investor | |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Accretion Pharmaceuticals IPO is up to ₹28.26 Cr whereas the issue size of the Divine Hira Jewellers IPO is up to ₹30.24 Cr. The final issue price of Accretion Pharmaceuticals IPO is ₹101.00 per share and of Divine Hira Jewellers IPO is ₹90.00 per share.
| Accretion Pharmaceuticals IPO | Divine Hira Jewellers IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹96.00 per share | |
| Issue Price (Upper) | ₹101.00 per share | |
| Issue Price (Final) | ₹101.00 per share | ₹90.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 1200 shares | 1600 shares |
| Fresh Issue Size | 27,98,400 shares | 33,60,000 shares |
| Fresh Issue Size (Amount) | up to ₹28.26 Cr | up to ₹30.24 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 27,98,400 shares | 33,60,000 shares |
| Issue Size Total (Amount) | up to ₹28.26 Cr | up to ₹30.24 Cr |
Accretion Pharmaceuticals IPO opens on May 14, 2025, while Divine Hira Jewellers IPO opens on Mar 17, 2025. The closing date of Accretion Pharmaceuticals IPO and Divine Hira Jewellers IPO is May 16, 2025, and Mar 19, 2025, respectively.
| Accretion Pharmaceuticals IPO | Divine Hira Jewellers IPO | |
|---|---|---|
| Anchor Bid Date | May 13, 2025 | |
| Issue Open | May 14, 2025 | Mar 17, 2025 |
| Issue Close | May 16, 2025 | Mar 19, 2025 |
| Basis Of Allotment (Tentative) | May 19, 2025 | Mar 20, 2025 |
| Initiation of Refunds (Tentative) | May 20, 2025 | Mar 21, 2025 |
| Credit of Share (Tentative) | May 20, 2025 | Mar 21, 2025 |
| Listing date (Tentative) | May 21, 2025 | Mar 24, 2025 |
| Anchor Lockin End date 1 | Jun 18, 2025 | |
| Anchor Lockin End date 2 | Aug 17, 2025 |
Accretion Pharmaceuticals IPO P/E ratio is 21.29, as compared to Divine Hira Jewellers IPO P/E ratio of .
| Accretion Pharmaceuticals IPO | Divine Hira Jewellers IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Accretion Pharmaceuticals Limited Financial Information (Restated Consolidated)
| Divine Hire Jewellers Limited Financial Information (Restated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 100.00 | 99.74 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 73.48 | 72.70 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 21.29 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹112.27 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 72.47% | 16.36% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 36.73% | 13.54% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 2.52 | 1.90 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹4.74 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 72.47% | 16.36% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Accretion Pharmaceuticals IPO Retail Individual Investors (RII) are offered 12,22,800 shares while in Divine Hira Jewellers IPO retail investors are offered 12,22,800 shares. Qualified Institutional Buyers (QIB) are offered 1,41,600 shares in Accretion Pharmaceuticals IPO and 0 shares in Divine Hira Jewellers IPO.
| Accretion Pharmaceuticals IPO | Divine Hira Jewellers IPO | |
|---|---|---|
| Anchor Investor Reserveration | 2,11,200 shares | 0 shares |
| Market Maker Reserveration | 1,47,600 shares | 1,77,600 shares |
| QIB | 1,41,600 shares | 0 shares |
| NII | 12,22,800 shares | 16,80,000 shares |
| RII | 12,22,800 shares | 16,80,000 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 27,98,400 shares | 33,60,000 shares |
Accretion Pharmaceuticals IPO subscribed 7.67x in total, whereas Divine Hira Jewellers IPO subscribed 3.93x.
| Accretion Pharmaceuticals IPO | Divine Hira Jewellers IPO | |
|---|---|---|
| QIB (times) | 12.14x | |
| NII (times) | 4.28x | 1.20x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 10.54x | 6.62x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 7.67x | 3.93x |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
